Previous 10 | Next 10 |
2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...
2024-03-31 19:46:03 ET More on Alphatec, Enovis Corporation, etc. IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF Alphatec Holdings, Inc. (ATEC) Q4 2023 Earnings Call Transcript Enovis Corporation (ENOV) Q4 2023 Earnings Call Trans...
2024-03-28 12:39:10 ET Read the full article on Seeking Alpha For further details see: NXST, GNTX, and COKE among the best mid-cap technical ideas - Roth MKM
Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced that management will participate in the upcoming 23rd Annual Needham Virtual Healthcare C...
2024-03-22 05:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Wilmington, DE, April 13, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2023 financial results on Thursday, May 4, 202...
2023-04-04 04:02:41 ET Summary Jeff Smith’s 13F portfolio value increased from $4.55B to $5.22B this quarter. Starboard Value added Salesforce and increased GoDaddy while decreasing Commvault Systems and dropping Huntsman Corp. The largest three individual stock positio...
2023-04-03 07:21:21 ET Enovis ( NYSE: ENOV ) announced a definitive agreement to acquire Novastep, a subsidiary of Amplitude Surgical, and global developer of clinically proven foot and ankle solutions. The transaction is expected to close in Q2 of 2023. A leading...
Wilmington, DE, April 03, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced a definitive agreement to acquire Novastep®, a subsidiary of Amplitude Surgical SA (Paris: AMPLI), and global developer of clin...
2023-03-15 16:39:47 ET Medical technology company Enovis ( NYSE: ENOV ) appointed CEO Matt Trerotola to the additional position of board chair, effective following the May 16 annual meeting of stockholders. Current Chair Mitchell Rales will retire on the same day...
News, Short Squeeze, Breakout and More Instantly...
Enovis Corporation Company Name:
ENOV Stock Symbol:
NYSE Market:
Wilmington, DE, May 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Bank of America Healthcare Conference: Ben ...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
Strong start to the year with sales growth of 27% on a reported basis and strong adjusted margin expansion Reported first-quarter net loss from continuing operations of $1.32 per share with adjusted earnings per diluted share of $0.50 Wilmington, DE, May 02, 2024 (GLOBE NEWSWIRE...